![PCR new 2014 masthead 1 1](https://prodcraftsa01.blob.core.windows.net/assets/products/primary-care-reports/_contentImage/PCR_new_2014_masthead_1__1.png)
Primary Care Reports – March 1, 2021
March 1, 2021
View Issues
-
Pharmacological Therapies in HFrEF: Is Quadruple Therapy a New Standard of Care?
Approximately 50% of patients with heart failure have heart failure with reduced ejection fraction (HFrEF). HFrEF morbidity and mortality are altered favorably with the use of guideline-directed medical therapy. Multiple drug therapies have informed evidence-based therapies for the treatment of HFrEF.